Radek Strnad
Thu, May 8, 2025, 11:39 AM 2 min read
Shares of biology services supplier Montrose (NYSE:MEG) jumped 14.7% successful the day league aft the institution reported beardown archetypal 4th 2025 results which importantly bushed analysts' revenue, EPS, and EBITDA expectations. Revenue climbed astir 15% from the aforesaid play past year, with spot successful the Measurement and Analysis and Remediation and Reuse segments much than offsetting declines successful exigency effect and permitting task revenues. Montrose besides announced its first-ever banal repurchase programme and completed a $60 cardinal preferred equity redemption, showcasing its equilibrium expanse spot and assurance successful aboriginal currency flows. Zooming out, we deliberation this was a bully people with immoderate cardinal areas of upside.
Is present the clip to bargain Montrose? Access our afloat investigation study here, it’s free.
Montrose’s shares are highly volatile and person had 52 moves greater than 5% implicit the past year. But moves this large are uncommon adjacent for Montrose and bespeak this quality importantly impacted the market’s cognition of the business.
Montrose is down 7.2% since the opening of the year, and astatine $17.38 per share, it is trading 65.1% beneath its 52-week precocious of $49.82 from May 2024. Investors who bought $1,000 worthy of Montrose’s shares astatine the IPO successful July 2020 would present beryllium looking astatine an concern worthy $789.77.
Here astatine StockStory, we surely recognize the imaginable of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could each person been identified arsenic promising maturation stories with a megatrend driving the growth. So, successful that spirit, we’ve identified a comparatively under-the-radar profitable maturation banal benefiting from the emergence of AI, disposable to you FREE via this link.